Open Label Pharmacokinetic Study of Granexin Gel in Patients With Diabetic Foot Ulcers

Trial Profile

Open Label Pharmacokinetic Study of Granexin Gel in Patients With Diabetic Foot Ulcers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2018

At a glance

  • Drugs ACT 1 (Primary)
  • Indications Diabetic foot ulcer
  • Focus Pharmacokinetics
  • Sponsors FirstString Research
  • Most Recent Events

    • 06 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Apr 2018.
    • 06 Feb 2018 Status changed from recruiting to active, no longer recruiting.
    • 28 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top